Brain tumors and neuro-oncology are integral to addressing the complexities of primary and secondary brain cancers. This specialized field encompasses a range of treatment options, from surgery and radiation therapy to cutting-edge drug therapies and clinical trials exploring new drug combinations. Researchers are focused on overcoming the challenges posed by the blood-brain barrier to deliver effective treatments. With the advent of immunotherapy, CAR-T cell therapies, and personalized genetic profiling, the landscape of neuro-oncology is rapidly changing. The development of non-invasive diagnostic tools and predictive models is also helping clinicians better assess tumor behavior and patient prognosis. This research is instrumental in improving long-term outcomes and offering hope to patients affected by malignant brain tumors.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany